17-63872301-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020991.4(CSH2):c.479G>A(p.Arg160Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,613,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020991.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSH2 | NM_020991.4 | c.479G>A | p.Arg160Gln | missense_variant | 5/5 | ENST00000392886.7 | NP_066271.1 | |
CSH2 | NM_022645.2 | c.194G>A | p.Arg65Gln | missense_variant | 3/3 | NP_072171.1 | ||
CSH2 | NM_022644.3 | c.*228G>A | 3_prime_UTR_variant | 4/4 | NP_072170.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSH2 | ENST00000392886.7 | c.479G>A | p.Arg160Gln | missense_variant | 5/5 | 1 | NM_020991.4 | ENSP00000376623 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152076Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 250820Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135632
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461614Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727120
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152076Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 31, 2024 | The c.479G>A (p.R160Q) alteration is located in exon 5 (coding exon 5) of the CSH2 gene. This alteration results from a G to A substitution at nucleotide position 479, causing the arginine (R) at amino acid position 160 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at